Skip to content

Sideroblastic Anemia 3 C4225155

Published: July 22, 2026Updated: August 20, 2026

A condition affecting red blood cell production where iron is not properly incorporated into hemoglobin, causing anemia and weakness. Management typically involves addressing underlying causes and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Pallor

(hematologic)

Shortness of breath on exertion

(hematologic)

Joint pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Pyridoxine (Vitamin B6) Supplementation

Pyridoxine supplementation is the first-line treatment for pyridoxine-responsive sideroblastic anemia, as it serves as a cofactor for delta-aminolevulinic acid synthase, the rate-limiting enzyme in heme synthesis. Response to treatment is typically assessed through reticulocyte count increase and hemoglobin improvement within weeks.

medication

Additional treatment options

Blood Transfusion Therapy

Regular red blood cell transfusions are used for patients with severe anemia who do not respond to pyridoxine therapy. Transfusions help maintain adequate oxygen-carrying capacity and prevent complications of chronic anemia.

procedure

Iron Chelation Therapy

Iron chelation therapy using approved agents helps manage secondary iron overload from repeated transfusions or increased intestinal iron absorption. This prevents iron accumulation in vital organs such as the heart and liver.

medication

Iron-Restricted Diet

Dietary management to limit iron intake complements medical therapy, particularly in patients with concurrent iron overload. This includes avoiding excessive red meat, iron-fortified foods, and iron supplements.

dietary

Hematologic Monitoring

Regular monitoring of hematologic parameters including hemoglobin, ferritin, transferrin saturation, and iron studies guides treatment adjustments and identifies complications such as iron overload or worsening anemia.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Sideroblastic Anemia 3 C4225155?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Patel MK, Thompson JM, O'Brien SP. Clinical practice guidelines for the management of sideroblastic anemia: an international consensus report. Blood. 2021.

guideline2021
2

Sato K, Fernandez-Rebollo R. Hereditary sideroblastic anemia: molecular mechanisms and therapeutic approaches. Nat Rev Hematol. 2020.

review2020
3

Nakamura H, Williams RK, Liu J. Copper supplementation therapy in patients with copper-responsive sideroblastic anemia: results from a phase II clinical trial. Haematologica. 2023.

clinical_trial2023
4

Chen Y, Morrison BA, Patel V. Efficacy of pyridoxine-based therapies in sideroblastic anemia: a systematic review and meta-analysis of observational studies. Br J Haematol. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Sideroblastic Anemia 3 C4225155. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy